vs
CLOVER HEALTH INVESTMENTS, CORP.（CLOV）与Magnera Corp（MAGN）财务数据对比。点击上方公司名可切换其他公司
Magnera Corp的季度营收约是CLOVER HEALTH INVESTMENTS, CORP.的1.6倍（$792.0M vs $487.7M），Magnera Corp净利率更高（-4.3% vs -10.1%，领先5.8%），CLOVER HEALTH INVESTMENTS, CORP.同比增速更快（44.7% vs 12.8%），Magnera Corp自由现金流更多（$-13.0M vs $-69.0M），过去两年Magnera Corp的营收复合增速更高（54.9% vs 18.6%）
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
CLOV vs MAGN — 直观对比
营收规模更大
MAGN
是对方的1.6倍
$487.7M
营收增速更快
CLOV
高出31.9%
12.8%
净利率更高
MAGN
高出5.8%
-10.1%
自由现金流更多
MAGN
多$56.0M
$-69.0M
两年增速更快
MAGN
近两年复合增速
18.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $487.7M | $792.0M |
| 净利润 | $-49.3M | $-34.0M |
| 毛利率 | — | 12.2% |
| 营业利润率 | -10.1% | 1.8% |
| 净利率 | -10.1% | -4.3% |
| 营收同比 | 44.7% | 12.8% |
| 净利润同比 | -123.2% | 43.3% |
| 每股收益（稀释后） | — | $-0.95 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLOVMAGN
| Q4 25 | $487.7M | $792.0M | ||
| Q3 25 | $496.6M | — | ||
| Q2 25 | $477.6M | $839.0M | ||
| Q1 25 | $462.3M | $824.0M | ||
| Q4 24 | $337.0M | $702.0M | ||
| Q3 24 | $331.0M | $332.1M | ||
| Q2 24 | $356.3M | $556.0M | ||
| Q1 24 | $346.9M | $558.0M |
净利润CLOVMAGN
| Q4 25 | $-49.3M | $-34.0M | ||
| Q3 25 | $-24.4M | — | ||
| Q2 25 | $-10.6M | $-18.0M | ||
| Q1 25 | $-1.3M | $-41.0M | ||
| Q4 24 | $-22.1M | $-60.0M | ||
| Q3 24 | $-9.2M | $-15.2M | ||
| Q2 24 | $7.4M | $19.0M | ||
| Q1 24 | $-19.2M | $14.0M |
毛利率CLOVMAGN
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 10.7% | ||
| Q1 25 | — | 10.7% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | 24.5% | 10.7% | ||
| Q2 24 | 30.3% | 6.6% | ||
| Q1 24 | 23.6% | 6.2% |
营业利润率CLOVMAGN
| Q4 25 | -10.1% | 1.8% | ||
| Q3 25 | -4.9% | — | ||
| Q2 25 | -2.2% | 1.5% | ||
| Q1 25 | -0.3% | 0.5% | ||
| Q4 24 | -6.4% | -3.1% | ||
| Q3 24 | -2.7% | 0.9% | ||
| Q2 24 | 2.0% | 3.1% | ||
| Q1 24 | -6.5% | 3.8% |
净利率CLOVMAGN
| Q4 25 | -10.1% | -4.3% | ||
| Q3 25 | -4.9% | — | ||
| Q2 25 | -2.2% | -2.1% | ||
| Q1 25 | -0.3% | -5.0% | ||
| Q4 24 | -6.6% | -8.5% | ||
| Q3 24 | -2.8% | -4.6% | ||
| Q2 24 | 2.1% | 3.4% | ||
| Q1 24 | -5.5% | 2.5% |
每股收益（稀释后）CLOVMAGN
| Q4 25 | — | $-0.95 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-0.51 | ||
| Q1 25 | — | $-1.15 | ||
| Q4 24 | — | $-1.69 | ||
| Q3 24 | — | $-0.33 | ||
| Q2 24 | — | $0.60 | ||
| Q1 24 | — | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.3M | $264.0M |
| 总债务越低越好 | — | $1.9B |
| 股东权益账面价值 | $308.7M | $1.0B |
| 总资产 | $541.0M | $3.9B |
| 负债/权益比越低杠杆越低 | — | 1.86× |
8季度趋势，按日历期对齐
现金及短期投资CLOVMAGN
| Q4 25 | $78.3M | $264.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $276.0M | ||
| Q1 25 | — | $282.0M | ||
| Q4 24 | $194.5M | $215.0M | ||
| Q3 24 | $288.0M | $230.0M | ||
| Q2 24 | $254.8M | $33.9M | ||
| Q1 24 | $208.3M | $30.2M |
总债务CLOVMAGN
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $877.4M | ||
| Q1 24 | — | $884.7M |
股东权益CLOVMAGN
| Q4 25 | $308.7M | $1.0B | ||
| Q3 25 | $340.9M | — | ||
| Q2 25 | $344.2M | $1.1B | ||
| Q1 25 | $336.1M | $1.1B | ||
| Q4 24 | $341.1M | $1.1B | ||
| Q3 24 | $342.2M | $2.1B | ||
| Q2 24 | $324.9M | $2.4B | ||
| Q1 24 | $292.5M | $2.4B |
总资产CLOVMAGN
| Q4 25 | $541.0M | $3.9B | ||
| Q3 25 | $559.7M | — | ||
| Q2 25 | $575.0M | $4.1B | ||
| Q1 25 | $583.7M | $4.1B | ||
| Q4 24 | $580.7M | $4.0B | ||
| Q3 24 | $653.0M | $2.8B | ||
| Q2 24 | $674.2M | $1.5B | ||
| Q1 24 | $671.8M | $1.5B |
负债/权益比CLOVMAGN
| Q4 25 | — | 1.86× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.77× | ||
| Q1 25 | — | 1.83× | ||
| Q4 24 | — | 1.80× | ||
| Q3 24 | — | 0.91× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 0.36× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-66.9M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $-69.0M | $-13.0M |
| 自由现金流率自由现金流/营收 | -14.1% | -1.6% |
| 资本支出强度资本支出/营收 | 0.4% | 1.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-69.2M | — |
8季度趋势，按日历期对齐
经营现金流CLOVMAGN
| Q4 25 | $-66.9M | $2.0M | ||
| Q3 25 | $12.1M | — | ||
| Q2 25 | $5.4M | $0 | ||
| Q1 25 | $-16.3M | $65.0M | ||
| Q4 24 | $34.8M | $-58.0M | ||
| Q3 24 | $50.0M | $12.2M | ||
| Q2 24 | $44.8M | $38.0M | ||
| Q1 24 | $25.9M | $20.0M |
自由现金流CLOVMAGN
| Q4 25 | $-69.0M | $-13.0M | ||
| Q3 25 | $11.4M | — | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | $-16.5M | $42.0M | ||
| Q4 24 | $33.3M | $-74.0M | ||
| Q3 24 | $49.6M | $3.6M | ||
| Q2 24 | $44.4M | $23.0M | ||
| Q1 24 | $25.5M | $12.5M |
自由现金流率CLOVMAGN
| Q4 25 | -14.1% | -1.6% | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | -3.6% | 5.1% | ||
| Q4 24 | 9.9% | -10.5% | ||
| Q3 24 | 15.0% | 1.1% | ||
| Q2 24 | 12.5% | 4.1% | ||
| Q1 24 | 7.3% | 2.2% |
资本支出强度CLOVMAGN
| Q4 25 | 0.4% | 1.9% | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.1% | 1.5% | ||
| Q1 25 | 0.0% | 2.8% | ||
| Q4 24 | 0.5% | 2.3% | ||
| Q3 24 | 0.1% | 2.6% | ||
| Q2 24 | 0.1% | 2.7% | ||
| Q1 24 | 0.1% | 1.3% |
现金转化率CLOVMAGN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 6.04× | 2.00× | ||
| Q1 24 | — | 1.43× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLOV
暂无分部数据
MAGN
| Other | $451.0M | 57% |
| United States And Canada | $341.0M | 43% |
